StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Non-GAAP Adjusted Diluted Earnings per ADS by Quarter

Non-GAAP Adjusted Diluted Earnings (Loss) per ADS ($/ADS) ($)

QuarterlyAnnual

BeOne Medicines Non-GAAP Adjusted Diluted Earnings per ADS: $3.84 in Q2 2026, up 70.7% from a year earlier. That is the highest of the 10 quarters on record here.

Latest, Q2 2026
3.84
Period ended Jun 30, 2026
Change on a year earlier
+70.7%
2.25 in Q2 2025
History
10 quarters
Since Q1 2024
Sources
6
Documents cited below

Where the Q2 2026 figure comes from

“|| Adjusted earnings per ADS - diluted | $ | 3.84 | $ | 2.25 | $ | 7.08 | $ | 3.48 1.Tax effect of Non-GAAP adjustments is based on the statutory tax rate in the relevant tax jurisdiction. Please note that the Company currently records a valuation allowance on its net deferred tax assets, so there is no net impact recorded for deferred tax effects.”

Source: Form 8-K (filed 2026-08-05) ↗

Reported in Form 8-K EX-99.1 Non-GAAP Reconciliation Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Adjusted Diluted Earnings (Loss) per ADS ($/ADS) ($)Year on yearSource
Q2 2026Jun 30, 20263.84+70.7%Form 8-K (filed 2026-08-05) ↗
Q1 2026Mar 31, 20263.24+165.6%Form 8-K (filed 2026-05-06) ↗
Q4 2025Dec 31, 20251.95+1,200.0%Form 8-K (filed 2026-02-26) ↗
Q3 2025Sep 30, 20252.65+452.1%Form 8-K (filed 2025-11-06) ↗
Q2 2025Jun 30, 20252.25+922.7%Form 8-K (filed 2025-08-06) ↗
Q1 2025Mar 31, 20251.22-187.1%Form 8-K (filed 2025-05-07) ↗
Q4 2024Dec 31, 20240.15–Form 8-K (filed 2026-02-26) ↗
Q3 2024Sep 30, 20240.48–Form 8-K (filed 2025-11-06) ↗
Q2 2024Jun 30, 20240.22–Form 8-K (filed 2025-08-06) ↗
Q1 2024Mar 31, 2024-1.40–Form 8-K (filed 2025-05-07) ↗

Cite this data

StockData. (2026). BeOne Medicines Non-GAAP Adjusted Diluted Earnings per ADS ($), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj-eps-ads-diluted

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.